Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | casein kinase i | 0.0333 | 1 | 1 |
Echinococcus multilocularis | casein kinase I gamma | 0.0267 | 0.7932 | 0.7932 |
Echinococcus granulosus | casein kinase I alpha | 0.0333 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0333 | 1 | 1 |
Echinococcus granulosus | casein kinase I gamma | 0.0267 | 0.7932 | 0.7932 |
Trypanosoma cruzi | casein kinase, putative | 0.0333 | 1 | 1 |
Leishmania major | casein kinase, putative | 0.0333 | 1 | 0.5 |
Trypanosoma cruzi | casein kinase, putative | 0.0333 | 1 | 1 |
Trypanosoma brucei | casein kinase I, isoform 2 | 0.0333 | 1 | 0.5 |
Loa Loa (eye worm) | protein kinase domain-containing protein | 0.0267 | 0.7932 | 0.7932 |
Echinococcus granulosus | casein kinase I delta | 0.0333 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0333 | 1 | 1 |
Entamoeba histolytica | casein kinase, putative | 0.0333 | 1 | 0.5 |
Onchocerca volvulus | 0.0328 | 0.9833 | 0.9833 | |
Echinococcus granulosus | casein kinase I delta | 0.0333 | 1 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0333 | 1 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0333 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0333 | 1 | 0.5 |
Echinococcus multilocularis | casein kinase I alpha | 0.0333 | 1 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-D protein kinase | 0.0333 | 1 | 1 |
Plasmodium vivax | casein kinase 1, putative | 0.0333 | 1 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0267 | 0.7932 | 0.7932 |
Echinococcus multilocularis | casein kinase I delta | 0.0333 | 1 | 1 |
Giardia lamblia | Kinase, CK1 Casein kinase | 0.0333 | 1 | 0.5 |
Entamoeba histolytica | casein kinase 1, putative | 0.0333 | 1 | 0.5 |
Echinococcus granulosus | casein kinase I alpha | 0.0333 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0333 | 1 | 0.5 |
Onchocerca volvulus | 0.0333 | 1 | 1 | |
Schistosoma mansoni | protein kinase | 0.0333 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0333 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0333 | 1 | 0.5 |
Trypanosoma cruzi | casein kinase, putative | 0.0333 | 1 | 1 |
Plasmodium falciparum | casein kinase 1 | 0.0333 | 1 | 0.5 |
Echinococcus multilocularis | casein kinase I alpha | 0.0333 | 1 | 1 |
Brugia malayi | casein kinase I | 0.0333 | 1 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0333 | 1 | 1 |
Loa Loa (eye worm) | casein kinase | 0.0262 | 0.7765 | 0.7765 |
Toxoplasma gondii | casein kinase I | 0.0333 | 1 | 0.5 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0333 | 1 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0333 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0267 | 0.7932 | 0.7932 |
Echinococcus granulosus | casein kinase i | 0.0333 | 1 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0333 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.